Men når disse resultater blev sammenholdt med resultaterne af de tre supplerende undersøgelser, fremgik det, at virkningen af Ebixa var mindre hos patienter med lettere sygdom.
However, when these results were considered along with those of the three additional studies, it was noted that the effect of Ebixa was smaller in patients with mild disease.